To our knowledge, no prospective study has investigated the effects ofthese SNPs on circulating ADAMTS13 and VWF levels and simultaneously the onset offuture cardiovascular events in CAD patients. This evidence concerns the gene ADAMTS13 and coronary artery disorder.